COMP <GO>
OVV vs CVX // 10Y YIELD & FRED MACRO BETA
Ovintiv Inc. (DE) (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: OVV 7
— CVX 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: CVX
LAST: $72.62 (+1.47%) • MKT CAP: $20.23B
macro-sensitivity
0.91
LAST: $235.52 (+1.75%) • MKT CAP: $457.31B
macro-sensitivity
1.07
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OVV VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OVV | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.30% | -0.30 | CVX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.70% | 5.80% | -0.10 | CVX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.3x | 21.5x | -13.20 | OVV | /valuation <GO> |
| Free Cash Flow Yield | 7.44% | 5.61% | +1.83 | OVV | /fcf-yield <GO> |
| Operating Margin | 13.10% | 8.10% | +5.00 | OVV | /operating-margins <GO> |
| Net Profit Margin | 14.30% | 6.70% | +7.60 | OVV | /net-margins <GO> |
| Revenue Growth (YoY) | -3.10% | -4.60% | +1.50 | OVV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.52% | 2.79% | -1.27 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.02 | 3.71 | -1.69 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.10% | -0.50 | OVV | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.9 | 72.8 | -1.97 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.91 | 1.07 | -0.16 | CVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.2x | 34.6x | -19.40 | OVV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.23B | $457.31B | -$437.08B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OVV REV | CVX REV | OVV GROSS % | CVX GROSS % | OVV FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.66B | $184.43B | 44.0% | 41.3% | $1.50B | $25.64B |
| FY 2024 | $8.94B | $193.41B | 44.0% | 38.4% | $1.42B | $22.79B |
| FY 2023 | $10.66B | $196.91B | 44.0% | 44.0% | $3.69B | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OVV // BETA 0.91
CVX // BETA 1.07